NEWSLETTER – WINTER 2025

SATA Council Updates – March 2025

1. The 2025 Symposium of the Society for Advancement of Transplant Anesthesia will be hosted at Hilton Hawaiian Village Waikiki Beach Resort, Honolulu, HI 98101. Registration (with CME credit): https://sata2022.wufoo.com/forms/r1n184420f1w9d7/ $50 for SATA, SOCCA and SCA members, $150 for non-members, free for trainees
2. SATA becomes an official ASA affiliated subspecialty Society! Please use this new logo.
3. The 2025 SATA Seed Grant winner is Ryan Nazemian, MD, PhD from Lahey Hospital & Medical Center, Beth Israel Lahey Health
4. Michael D. Kaufman MD became the FIRST Fellow of the Society for the Advancement of Transplant Anesthesia (FSATA).

This designation indicates the SATA member has demonstrated, “Leadership in Transplant Anesthesia”. The SATA Council said “By offering this designation, anesthesiologists will have another tool to display to their colleagues and the medical community the high-quality proficiency of skills that are required in today’s anesthesiology world.”  The SATA thoughtfully developed the criteria for this designation, emphasizing the experience and education of the applicant and peer recommendations.  With this designation we hope to recognize those individuals around the globe who have excelled in various aspects of periprocedural and/or perioperative management.

Eligibility criteria for FSATA include current active physician membership in SATA, a letter of support from a senior level clinician or administrator, a minimum of 5 years of leadership or management experience, a personal statement describing prior experience and qualifications, having attended at least 1 of the last 3 Annual SATA National Meeting Meetings.

For more information on the eligibility criteria and application process, please go to the SATA website (http://www.transplantanesthesia.org) or email us at sata@pacainc.com. 

     5. SATA clinical resources are moving to C8 Heath

What is C8 Health?

C8 Health is a knowledge management platform for healthcare. It was founded by providers for providers to make best practices accessible to everyone, anywhere, at any time. Knowledge on the platform is always up to date, relevant and easy to access on any device.

How will C8 Health benefit me as a clinician?

• C8 Health allows you to easily access SATA-provided clinical resources. It offers the tools to get the answers you need, when and where you need them:
• Powerful search capabilities and natural language questions allows you to get immediate answers to questions, using SATA-provided knowledge
• Content is easy to read and navigate on any device, mobile, web or hospital workstations
• What problem does C8 Health solve?

-Realtime easy access to clinical resources (protocols and guidelines), in one place.

            -Effective dissemination of new content and content updates to clinicians

How do I access the C8 Health platform?

• Login to access via the C8Health app (App Store or Google Play) or on the webApp. Follow the steps here to login. Your login is your email you used for SATA application.

I already have access to C8 from my institution, and I am a SATA member. How do I switch from my organization’s instance to SATA’s?

• You can easily switch between organizations. Follow the steps here

Can I share content?

• You can easily share content with any other C8 user of SATA. On our WebApp, simply copy the resource’s URL and send it to the person. On mobile, it’s just a few taps as well.

For any questions – contact support@C8Health.com

UNOS News

By Flora Simmons, MD

Record-breaking 48,000 Transplants Performed in 2024

According to data from the Organ Procurement and Transplantation Network (OPTN), the US has performed over 48,000 organ transplants in one year. UNOS continues to engage with Congress and other stakeholders to advocate for pragmatic policy changes that can benefit the transplant community. Link here

Six-minute Walk Test Now Standardized

A new policy has been implemented that requires lung transplant programs to perform an oxygen titration test ahead of the six-minute walk test for lung candidates 12 years or older. This policy change aims to standardize the six-minute walk test and subsequently promote equity.  Link here

UNOS CEO Urges Congressional Action on Lifesaving Reforms

The CEO of the United Network for Organ Sharing (UNOS) is requesting federal action by Congress on numerous reforms to the organ donation and transplantation system. These reforms aim to remove barriers, increase efficiency, and reduce organ non-use.

Four key proposals outlined:

• Mandate automated donor referrals to optimize the donor referral process
• Mandate in-cabin airline transportation for organs
• Mandate organ tracking for unaccompanied organs
• Incentivize transplant hospitals to accept hard-to-place organs and reduce organ non-use. Link here

SATA Member Corner: 5 minutes with Dr. Kyota Fukazawa from University of Washington

By Alex Ruan, MD

Can you share a little bit about your background and your journey to a career in medicine?

After graduating from medical school, I worked as a faculty member for about five years in Japan. I developed a strong interest in liver transplantation and decided to come to the United States for advanced anesthesiology training. I visited the liver transplant program at Baylor University Medical Center, where Dr. Michael Ramsay taught me the fundamentals of liver transplant anesthesiology and shared his philosophy on managing liver cases. He also created opportunities for me to join rounds with the transplant surgical team and participate in organ harvesting, which was an exciting experience for me. Following this, I pursued a fellowship in transplant anesthesiology and later became a faculty member at the University of Miami. Under the guidance of Dr. Ernesto Pretto, I learned many tips and techniques for managing transplant anesthesiology and participated in various research projects, including both basic and clinical science. I left the University of Miami in 2014 and moved to the University of Washington.

Why transplant anesthesiology? Do you have a role in your group?

I enjoy analyzing hemodynamic data to make treatment decisions during transplants. Additionally, most transplant recipients are thrilled to enter the operating room after months of waiting, and I find it rewarding to help these happy patients. I currently serve as the Chief of Transplant Anesthesiology and the Director of the Transplant Anesthesiology Fellowship at the University of Washington.

Why did you join SATA? How long have you been a member of SATA and what is your current involvement with the organization?

I am a founding member of SATA and have been involved since its inception. Currently, I serve as the Senior Chair of the Meeting Committee for the SATA West Coast Annual Regional Seminar, and I am a member of the Fellowship Committee, the Federation (International Relations) Committee, the Abdominal Transplant Task Force Committee, and the Practice Management Committee.

What are your research interests, and do you currently have any research/ clinical projects going on?

My research focuses on finding ways to improve outcomes and the quality of care in liver transplant using both national databases and institutional data. My current projects include: pain management in liver transplant, TEG and liver transplant outcomes, anesthesia quality measures in liver transplant, size mismatch in liver transplant, outcomes of various cardiac diseases in liver transplants, machine preservation and its associated outcomes in liver transplant, risk factors for post-reperfusion syndrome, practice management for liver transplant, and transplant education for anesthesia residents.

What is your favorite piece of anesthesia equipment?

The anesthesia machine is my favorite piece of equipment; it brings me a sense of relaxation when I see it in the procedure room.

What do you enjoy doing outside of work?

I enjoy spending time with my family. In my free time, I like exercising, hiking, running, and skiing.

What advice would you give to a medical student or resident who is interested in liver transplant?

Transplant anesthesiology is one of the most exciting fields within anesthesia. We use many monitors, similar to commercial airline pilots, to make the safest management decisions. During anesthesia residency, it would be beneficial to master the following two key areas. First, become familiar with transplant procedures, as anesthesia management requires planning that incorporates expected hemodynamic changes associated with the surgical procedure. Second, gain a solid understanding of anesthesia management for various comorbid conditions and intraoperative events. While anesthesia management can be challenging, you will feel a significant sense of accomplishment once you transfer the patient to the SICU after a transplant.

How can we reach you?

e-mail: fukazawa@uw.edu or via SATA Instagram via @transplant.anesthesia

If you or someone you know is interested in being featured in the SATA newsletter, please reach out to Dr. Alexandra Ruan aruan@stanford.edu

The Research Corner

By Michael Trostler, MD and Alex Stoker, MD

“2024 Clinical Update in Liver Transplantation”

This well done review of 2024 highlights key areas of development and areas in need of development.  Regional anesthesia in liver transplant focusing on subcostal TAP block, but may include the Intercostal External Oblique Block in the coming year as presented as ASRA.  Intraoperative clotting during transplant focusing on intracardiac thrombus and its management with heparin, tPA, and ECMO.  Dynamic outflow obstruction, and a section on combined Heart-Liver transplantation.

“Beating Heart Transplant Procedures Using Organs From Donors With Circulatory Death | Surgery | JAMA Network Open”

In this case series of 10 patients undergoing orthotopic heart transplantation, a team utilized cardiac allografts from DCD donors and eliminated the need for a second warm ischemic time by transitioning the allografts from transportable normothermic machine perfusion to perfusion by the recipient cardiopulmonary bypass circuit while still beating. By eliminating the need for a second cardioplegic arrest and ischemia reperfusion injury, this could potentially improve organ function. The authors describe that none of these patients required post op mechanical circulatory support and all survived.

“Impact of differential glycemic management goals in pre-anhepatic and anhepatic phase on early grafted liver function after liver transplantation: An open-label, randomized, controlled study”

Less restrictive glucose control leads to less early allograft dysfunction.  188 Liver transplant recipients were targeted to either Glucose of 80-120 mg/dL or 140-180 mg/dL in a 1:1 ratio with less restrictive glucose control during pre-anhepatic and anhepatic phases with a RR 0.32 of early allograft dysfunction with glucose 140-180 (10.1% vs 31.2% for each group respectively)

“Simultaneous liver transplant and sleeve gastrectomy provides durable weight loss, improves metabolic syndrome and reduces allograft steatosis”

Liver transplant and sleeve gastrectomy confers metabolic benefit with decreased prevalence of diabetes, hypertension, weight loss.  There was a trend towards decreased fibrosis but this did not reach statistical significance (RR 0.46, p=0.09).

“To Err Is Robot – an analysis of complications following robotic donor hepatectomy”

348 Living donor liver transplants were performed at the Amrita Institute of Medical Sciences and Research Center in Kochi, Kerala, India.  Robotic donor hepatectomy had a low conversion to open rate (3.4%) and overall complication rate of 9.9% compared with open donor hepatectomy with 21.7% overall complication rate.  There were significantly less complications in the second half of their recruitment period showing a collective learning curve.

Special Topics
By Alex Stoker, MD

Estimation of Right Ventricular Systolic Pressure (RVSP) using TEE

An alternative approach to monitoring pulmonary artery pressure with a pulmonary artery catheter is to estimate RVSP using TEE which should approximate systolic pulmonary artery pressure in the absence of right ventricular outflow tract obstruction. RVSP is commonly estimated using the simplified Bernoulli’s equation (RVSP = 4* (max tricuspid regurgitation velocity)²  + CVP). Continuous wave Doppler is used to measure peak tricuspid regurgitation velocity and frequently performed in the mid esophageal (ME) 4 chamber, ME RV inflow-outflow, or ME modified bicaval view. A good Doppler signal is important for estimation. A recent prospective study found poor agreement between RVSP and direct PA catheter measurements, particularly if the Doppler signal is poor. These authors found the best correlation in patients with severe TR who had a full jet envelope. Below is an example of a continuous wave spectral doppler profile obtained in the ME modified bicaval view to estimate peak tricuspid regurgitation velocity. RVSP estimation using TEE is a powerful tool, however it is important to recognize limitations, particularly if a poor Doppler profile is obtained.

Fig. 1: Continuous wave Doppler measuring tricuspid regurgitation velocity, obtained in the mid esophageal modified bicaval view.

Reference:  https://pmc.ncbi.nlm.nih.gov/articles/PMC8376331/

In the Spotlight: Emory University Hospital

By David Rosenfeld, MD, FASA

In this Winter 2025 Newsletter we highlight Emory University Hospital Transplant Program.  We would like to thank liver anesthesiologist Dr. Flora Simmons for providing details about their abdominal program, and Cardiac Division Chair Dr. Ellen Richter, and CT Anesthesia Operations Chief, Andrea Corujo-Rodriguez for details on the Cardiothoracic program.

Emory performed the first liver transplant in the state of Georgia back in 1987. Since then, they have cared for some of the most complex liver transplant patients in the Southeast.  They are one of the few programs that utilize the Molecular Adsorbent Recirculating System (MARS) for management of fulminant hepatic failure. MARS is a liver support system that uses an albumin-enriched dialysate to facilitate the removal of albumin-bound toxins. 161 cadaveric liver transplants were performed at Emory per year from SRTR 12-month data. They are also a busy renal center with 251 cadaveric, 97 living related, and 12 kidney-pancreas in that interval ending June 2024. They have a dedicated team of transplant anesthesiologists who cover the liver transplants 1:1 with residents and anesthetists involved. Residents are introduced to liver transplants early in their training starting as CA1s.  A non-ACGME liver transplant anesthesia fellowship was started in 2016.  Along with intraoperative management, fellows participate in supervision of residents, postoperative visits, weekly selection conference, and M&M conference. Liver transplants are commonly performed via piggyback technique, with caval exclusion cases being performed without veno-veno bypass when needed. Within the last year, they have increasingly employed the TransMedics Normothermic Perfusion System, for organ resuscitation.  TEE is not universal but often utilized in more complex cases.  ROTEM point of care testing is run in room, with TXA utilized only in cases of severe hyperfibrinolysis. About 60% of liver transplants are extubated in the OR before transfer to the ICU.

Emory has a busy cardiothoracic transplant program with 71 heart transplants performed in 12 months, 26 lungs, and 14 combined heart/lung.  They have a large group of CT anesthesiologists with 18 dedicated cardiac, and another 7 who split time with the general team.  They have a large CT anesthesia fellowship with six fellows led by Program Director Dr. Ratna Vadlamudi.  Their care ratio is 1:2 direction with fellows, residents, or anesthetists. Fellows will gain more autonomy and assume a junior attending role in the later stages of the experience supervising 1–2 rooms, including transplant rooms, under the guidance of the attending.  Emory has advanced the use of DCD donors with 19 hearts and 7 lungs transplanted last year. They are helping to pioneer beating heart DCD with two performed to date.  VA ECMO is utilized for double lungs, with the goal to avoid ECMO in single organs.  Dr. Corujo-Rodriguez serves as the liaison to the heart transplant service and has been part of a multidisciplinary effort (involving the cardiac ICU and surgical colleagues) to ensure standardization of heart transplant care while continuing to advance practice and transplant techniques. Dr. Ragini Gupta joined the faculty last year from Temple University, a high-volume lung transplant center, and is the group’s liaison for lung transplantation working alongside surgical colleagues.

If interested in having your program highlighted in the future, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

SATA Committee and Leadership Updates

Pediatric Committee Update – Marina Moguilevitch, MD

The pediatric committee successfully completed and published a comparison of pediatric anesthesia practices with new organ procurement and transplant network pediatric policy requirements. The group took on to follow up on that and now plans to look at specific practices/trends of pre, intr, and postoperative pediatric liver transplant case management. They are in the final stages of preparing a national survey examining these practices with the hope to identify trends and offer specific recommendations.

Vanguard and Fellowship Committees – Ryan Chadha, MD

1. We are starting a journal club to be done on a roughly quarterly basis with a fellow led by a senior mentor on a recent transplant-related journal publication. The first one is May 5, led by Christy He, a transplant fellow from Columbia-NYPH.
2. In C8, there is a new fellow’s corner being developed to house links to all relevant online transplant resources

Upcoming Events and Meetings

SATA Meetings:

The 2025 Symposium for the Society for the Advancement of Transplant Anesthesia

SATA Annual Meeting, Honolulu, HI

Monday March 23, 2024

Other Meetings:

The International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting

Boston, MA, April 27-30

UNOS Transplant Management Forum

San Antonia, TX, May 5-7, 2025

The International Liver Transplant Society (ILTS) Annual Congress

Singapore, May 28-31, 2025

SATA BOARD OF DIRECTORS: TERM  2024 – 2025

President
 Gebhard Wagener, MD

Immediate Past President
 Tetsuro Sakai, MD, PhD, MHA, FASA

 Founding President
 Ernesto A. Pretto Jr., MD, MPH

 President-elect
 Lorenzo De Marchi, MD

Secretary
Jiapeng Huang, MD, PhD, FASA, FASE

Treasurer
Ranjit Deshpande, MBBS

Executive Council

Michael Ander, MD, FASA

Richa Dhawan, MD

MIchael D. Kaufman, MD, FASA

Raymond M. Planinsic, MD, FASA

Newsletter Editor-in-Chief
 David Rosenfeld, MD, FASA

 Newsletter Editorial Board

Sennaraj Balasubramanian, MD

Amit Bardia, MD

Andrew Gorlin, MD

Jiapeng Huang, MD, PhD, FASA, FASE

1. Susan Mandell, MD, PhD

Sergio Navarrete, DO

Yong G Peng MD, PhD

Alexandra Ruan, MD

Flora Simmons, MD

Natalie Smith, MD

Alex Stoker, MD

Michael Trostler MS, MD

NEWSLETTER – SUMMER 2025

UNOS News

By Flora Simmons, MD

Organ donor hospitals and transplant hospitals – how do they differ?

Donor and transplant hospitals both play important roles in saving lives and making transplantation possible.  Donor hospitals are not members of the national Organ Procurement and Transplantation Network (OPTN) and are not subject to OPTN policies or requirements.  They must comply with state and federal laws regarding identification and referral of donors. The organ procurement organization (OPO) managing the logistics of the donation process is still accountable to CMS requirements and OPTN policies. Hospitals accredited to perform organ transplants are accountable to state and federal laws. Each transplant hospital must also be a member of the OPTN and must abide by the OPTN policies and bylaws. An institution can function as both a donor and a transplant hospital as long as it meets OPTN standards and requirements.

How UNOS uses data to help transplant programs improve

UNOS uses organ donation and transplant data to determine key trends and identify ways the system can more efficiently help people receive a transplant. UNOS accesses this information by submitting data requests to the Organ Procurement and Transplantation Network (OPTN) which compiles data on transplant recipients, candidates, and organ donors. Any individual or OPTN member can submit a data request by completing a form on the OPTN website. UNOS follows the same steps as everyone else to request data. UNOS uses its analytics team to help devise performance improvement tools that can be used by transplant hospitals and organ procurement organizations (OPOs).  Analytics can be used to create solutions for organ transportation such as the UNOS organ tracking service that allows transplant hospitals oversee organ shipments in real-time. UNOS research and decades of insights can also be used to develop customized registries and clinical databases to provide cost-effective solutions and improvement/outcome registries. 

SATA Member Corner: 5 minutes with Dr. Natalie Smith from Mount Sinai Hospital

By Alex Ruan, MD

Can you share a little bit about your background and your journey to a career in medicine?
Originally, I am from New York and attended the University of Michigan for my undergraduate studies before returning to NYU for medical school. After medical school, I moved to the Upper East Side to Mount Sinai Hospital, where I have been ever since.  Both of my parents are doctors, and my grandfather was a surgeon in a small town in Ohio. While I never felt pressured to become a doctor as a child, it seemed like the natural path for me. My brother is also a surgeon, so it feels like a family tradition.

Why transplant anesthesiology? Do you have a role in your group?
I am currently the director of the Liver Transplant Division and the Fellowship director for transplant at Mount Sinai Hospital in New York City. I have always been drawn to larger cases where anesthesiologists play a significant role. I loved cardiac anesthesia, but I found that transplant cases, which generally do not involve bypass, presented a different kind of challenge. I liked the acuity and pressure of transplant cases. We also have a very nice team of surgeons, and the rapport between the surgical and anesthesiology team drew me in as well. I have been lucky to become the director of the team and to teach the next generation of fellows.

Why did you join SATA? How long have you been a member of SATA and what is your current involvement with the organization?
Like a lot of others, I learned about and joined SATA through word of mouth, primarily encouraged by Dr. Jeron Zerillo, who was very involved in SATA at Mount Sinai. He played a significant role in the organization during the 2010s and encouraged me to get involved and get to know all these people from around the country and even the world who had this interest in transplant anesthesia. My initial involvement was with the Newsletter Committee. At the time, we were writing the newsletter and trying to send it out without any office staff, so I helped format it and get it into HTML, so we could send it over email. Over time, I’ve gotten into other roles. I’m most involved now with Vanguard, which is the committee to help get younger transplant physicians involved. We work with other committees, like the Education Committee to make sure junior attendings can get involved with programming for meetings and get opportunities to speak and network. We created a subcommittee to keep members engaged through social media, and this past year created a new mentorship program.

What are your research interests, and do you currently have any research/ clinical projects going on?
As a division, we collaborate on various research projects. Our research director, Dr. Ryan Wang, is heavily involved in several initiatives, including projects with the SATA liver transplantation QI database in collaboration with UCSF and other groups. I am very interested in quality improvement and safety initiatives. Ryan and I recently implemented a new protocol for managing hyperkalemia with high-dose insulin infusions; Dr. Christine Nguyen-Buckley from UCLA helped us with that.

What is your favorite piece of anesthesia equipment?
I love RIC (rapid infusion catheter) lines! They’re easy to put in, and I think they’re the most valuable line in any case where you have to transfuse, even better than all central lines.

What do you enjoy doing outside of work?

Outside of work, I enjoy spending time with family and friends, cooking, and skiing.  My 18-month-old is my main hobby right now. I’m always looking for new recipes I can cook that I can share with her and introduce her to new foods. I also bought her a little pair of skis that she has been walking around the house with, so next year I hope to finally put her in real skis!

What advice would you give to a medical student or resident who is interested in liver transplant?
I would encourage medical students and residents to stay open-minded about their paths in medicine. There are so many ways to get involved in liver transplant if that’s what you’re interested in, whether through medicine, anesthesia, surgery, immunology, or hematology – there’s just so many people who are involved with the transplant process.  Of course, I always encourage everyone to pursue liver transplant anesthesia if they’re interested. It’s a smaller field and we get less exposure to it so it can be daunting to decide to pursue it. But the skills that you learn from doing transplant makes you so adaptable, and you’re taking care of the sickest possible patients. There are so many transplant centers out there and our ability to do more and more transplants is increasing especially in the era of machine perfusion so the need for transplant anesthesiologists will continue to grow.

How can we reach you?

You can reach me at natalie.smith@mountsinai.org. You can also learn more about our program at our Fellowship website: https://icahn.mssm.edu/education/residencies-fellowships/list/msh-liver-transplant-fellowship of follow the Sinai Instagram: @mountsinaianesthesiology

If you or someone you know is interested in being featured in the SATA newsletter, please reach out to Dr. Alexandra Ruan aruan@stanford.edu

The Research Corner

By Michael Trostler, MD and Alex Stoker, MD

“The role of veno-venous bypass in liver transplant” Ahrens et al.

Veno-Venous Bypass (VVB) is a standard of care at some institutions with either portal bypass or portal and caval bypass.  The hypothesis was that VVB would improve renal perfusion and, but this was only shown to be effective in bicaval not piggyback technique.  As long as piggyback technique is used there were less transfusions and bleeding without VVB.

“Vasopressin Is Not Associated With Severe Kidney Injury in Liver Transplantation: A Propensity Score-adjusted Analysis” Antonucci et al.

Acute Kidney Injury (AKI) is a common complication after liver transplants.  AKI is associated with decreased graft survival, higher morbidity and mortality, and increased chronic kidney disease.  Vasopressin can be theorized to decrease the incidence of post-operative renal dysfunction through mechanisms of increased GFR, limitation on catecholamine induced renal vasoconstriction, and prevention of sympathetic overactivation.  This study was a retrospective analysis of 1120 patients found that vasopressin use was not associated with severe AKI after liver transplant and was not associated with increased graft failure over time.  Patients receiving vasopressin did received less catecholamine vasopressors.

“Vasoplegia in Heart, Lung, or Liver Transplantation: A Narrative Review” Ortoleva et al.

This narrative review is an excellent overview of the mechanisms underlying vasoplegia and the mechanisms of the common treatment agents that are used when our normal vasopressors are inadequate (Methylene Blue, Hydroxycobalamin, Angiotensin II).

In the Spotlight:  University of Florida Health – Gainesville – Lung Transplant

By David Rosenfeld, MD, FASA

We had the opportunity to learn about UF Health’s extensive lung transplant program through Drs. T. Everett Jones and Yong Peng.  The Gainesville program is anchored out of the UF Heath Shands Hospital, a sprawling 1,111 bed facility with 241 ICU beds.  As a transplant center they are thriving, with SRTR 12 month data showing 158 cadaveric livers, 64 kidneys, 10 kidney-pancreas, 58 lungs, and 16 hearts.

The UF Health Lung Transplant program is under the medical directorship of Dr. Amir Emtiazjoo, with Dr. Mindaugas Rackauskas as surgical director.  Patients are reviewed weekly through their multidisciplinary Medical Review Board which includes pulmonary CCM, thoracic surgeons, anesthesiology, psychology, physical therapy, and dieticians.  Cardiothoracic anesthesiologists have developed standardized protocols to help guide management and reduce significant variability in practice during the intraoperative phase.   In 2014 elective intraoperative VA ECMO during lung transplantation was adopted for most cases to reduce allograft reperfusion injury and increase cardiopulmonary stability during cardiac manipulation with ICU based ECMO commonly used as a bridge to transplantation.  Outcomes are high quality, ranking as the top program in Florida and top 5 in the country for one year survival according to the 2024 SRTR data.  During the pandemic they were one of the largest volume centers performing more than 30 bilateral lung transplantation cases for end stage post COVID complications with their experience currently being submitted for publication.  Point of care coagulation testing with Quantra has been adopted since 2018 to assist with ECMO induced coagulopathy and has led to reduced transfusion requirements.   They contribute to expanding the donor pool aiming to prolong the time for which lungs can be transplanted safely without a detriment to outcomes including being one of the first institutions to use ex-vivo perfusion rehabilitation prior to transplantation. UF transports lungs using the BaroGuard system. They have been studying the effects of cold storage at 10 ^OC overnight for semi-elective lung transplantation during the next day, and use intraoperative plasma exchange for highly sensitized patients at high risk of antibody mediated rejection.  Combined lung/liver and lobar transplants are part of the practice as well.  Members of their Cardiothoracic Anesthesia Division have collaborated with several centers researching the rate of blood transfusion in lung transplantation and collaborated with SATA reporting on the national trends related to the use of extracorporeal life support in lung transplantation (the SEAL study).  Truly a remarkable and mature program at UF.   

If interested in having your program highlighted, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

SATA Committee and Leadership Updates

From the Fellowship Committee

The SATA Fellowship Committee is excited to sponsor the SATA Liver Transplant Anesthesia Fellow Journal Club. Dr. Christy He from Columbia University presented the first journal club session on the article by Lacom et al.: Safety and Feasibility of Early Extubation in Liver Transplantation. The next Liver Transplant Anesthesia Fellow Journal Club presentation will be Monday, September 15 – more information to come. Don’t miss out on the discussion!

 For members only, a Fellowship Corner has been created on c8. Fellowship lectures can be found here: https://app.c8health.com/knowledge?category=66d770662885a348e8eccbed

For a fellow reading list curated by liver transplant anesthesiology experts, go to:  https://app.c8health.com/knowledge/67f8428e3c70605969d1ad5d

Upcoming Events and Meetings

ILTS/SATA Perioperative Care in Liver Transplantation Meeting

Please join us on October 10, 2025 for the 2025 Perioperative Care in Liver Transplantation meeting, jointly organized by the International Liver Transplant Society (ILTS) and the Society for the Advancement of Transplant Anesthesia (SATA) at the University of Texas, Health Science Center at San-Antonio on Friday, October 10, 2025.  https://www.ilts.org/perioperative-meeting

SATA West Coast Meeting

Please join us on Saturday, December 13, in Los Angeles with a hybrid (in-person and zoom) format. Sessions include the evolving role and application of ECMO during liver transplantation, emerging technologies and issues in liver transplantation, and expert panels on cardiac evaluation in liver transplantation and transfusion practices and patterns. Reserve the date on your calendar and more details will be sent to SATA members in the near future.

World Transplant Congress (WTC)

The World Transplant Congress is a joint meeting organized by the AST, the American Society of Transplant Surgeons (ASTS), and The Transplantation Society (TTS). This international event will take place from August 2-5, 2025, in San Francisco, CA.  https://wtc2025.org/

International Transplantation Science (ITS)

The ITS meeting is a joint effort between the AST, the European Society of Organ Transplantation (ESOT), and The Transplantation Society (TTS). The next meeting will be hosted in San Diego, CA, November 16 – 19, 2025. https://www.myast.org/its2025/its-registration

SATA BOARD OF DIRECTORS: TERM  2024 – 2025

President
 Gebhard Wagener, MD

Immediate Past President
 Tetsuro Sakai, MD, PhD, MHA, FASA

 Founding President
 Ernesto A. Pretto Jr., MD, MPH

 President-elect
 Lorenzo De Marchi, MD

Secretary
Jiapeng Huang, MD, PhD, FASA, FASE

Treasurer
Ranjit Deshpande, MBBS

Executive Council

Michael Ander, MD, FASA

Richa Dhawan, MD

MIchael D. Kaufman, MD, FASA

Raymond M. Planinsic, MD, FASA

Newsletter Editor-in-Chief
 David Rosenfeld, MD, FASA

 Newsletter Editorial Board

Sennaraj Balasubramanian, MD

Amit Bardia, MD

Andrew Gorlin, MD

Jiapeng Huang, MD, PhD, FASA, FASE

Susan Mandell, MD, PhD

Sergio Navarrete, DO

Yong G Peng MD, PhD

Alexandra Ruan, MD

Flora Simmons, MD

Natalie Smith, MD

Alex Stoker, MD

Michael Trostler MS, MD

UNOS News

By Flora Simmons, MD

White Paper Analyzes the Ethical Issues in Normothermic Regional Perfusion

The OPTN board has approved release of a white paper addressing the ethical principles involved in normothermic regional perfusion (NRP), an approach to help facilitate improved organ function after cessation of circulation in donation after circulatory death cases. Ethical concerns have been raised given the involvement of recirculation after declaration of death. This white paper reviews the ethical implications of NRP according to established ethical principles guiding donation and transplantation. Link here

SATA Member Corner: 5 minutes with Dr. Ryan Nazemian from Lahey Hospital and Medical Center

By Alex Ruan, MD

Can you share a little bit about your background and your journey to a career in medicine? 

I grew up and went to medical school in Yazd, Iran. Right after medical school, I moved to the United States and found a research position in Cleveland, Ohio, and did my PhD at Case Western Reserve University. My PhD research mentor, James Reynolds, was doing basic science and pharmacology research in anesthesiology. We were working on organ donors and nitric oxide bioactivity. I got introduced to anesthesiology through him, and then I worked with a couple anesthesiologists there. After finishing my PhD, I matched at the anesthesiology program at Case Western Reserve University. 

Why transplant anesthesiology?

During residency, I liked the transplant cases. I really like big complex cases. And that made me look into liver transplant fellowship programs and found Lahey here in Burlington, Massachusetts.  I came here for fellowship and stayed on ever since.

I really like the complexity of the cases, and the fact that we are very involved with the patient care perioperatively. I think liver transplant is one of the most beautiful procedures that we can do – every case is different and has its own challenges, and once the liver starts working, the patient becomes a completely different person. And of course, given my research background, I really like the research part of it. I think there’s still many, many things that we don’t know about transplant anesthesia and transplant in general. So I think it’s actually a very young field, and there are a lot of opportunities here.

Why did you join SATA? How long have you been a member of SATA and what is your current involvement with the organization?

I found SATA one day during an online search as I was just starting to look into transplant anesthesiology. I found Lahey Clinic through the SATA fellowship database, actually. I’ve really enjoyed being involved with SATA, through it I’ve made a lot of friends, you, Dieter Adelmann, Michael Bokoch, and others that I enjoy collaborating with. I also enjoy going to the meetings – all our meetings are extremely educational and it’s a great opportunity to regularly connect with people. I’m currently part of the Vanguard Committee and lead the Social Media Subcommittee efforts. 

What are your research interests, and do you currently have any research/ clinical projects going on?

My research interest has always been the field of transplantation in general. I started with organ donors, but now my research is on outcomes, such as fast-track and ERAS protocols. I am working on the early extubation project that several centers are involved through the SATA database. I also have a project looking at the use of methadone and ketamine for pain management in liver transplantation, which we just presented at ILTS.

What is your favorite piece of anesthesia equipment? 

I really like 14g IVs and MAC lines. IVs are such a simple but effective anesthesia instrument. It definitely has saved me many times in the operating room. It’s quite cheap, and so effective. Also, the MAC line – I use it in all my liver transplant cases, It’s relatively easy to place, and overall can be used for many things such as massive blood transfusion

What do you enjoy doing outside of work? 

I really enjoy spending time with my family. I have a 2-year-old son, and we are expecting another baby soon. I also love watching movies and sports on TV. I’m a huge fan of FC Barcelona and I watch all their games. I’m hoping that once my son is older, we can go to Barcelona and watch some games together. 

What advice would you give to a medical student or resident who is interested in liver transplant? 

I encourage everyone to have an open mind on their transplant rotation – some medical students and residents get intimidated by liver transplant because some of these patients are quite sick. I remember I had a resident once and they had a quite challenging month. But then, at the end of the month. I took them to the post-op floor, and we saw some of those patients walking and talking and laughing, which was really amazing.

Dr. Nazemian can be reached at ryan.nazemian@lahey.org or via the SATA Instagram via @transplant.anesthesia

If you or someone you know is interested in being featured in the SATA newsletter, please reach out to Dr. Alexandra Ruan aruan@stanford.edu

In the Spotlight: University of Michigan Medical Center

By David Rosenfeld, MD, FASA 

We would like to thank Dr Sathish Kumar, Section Head and Medical Director of Transplant Anesthesiology for University of Michigan, for providing us with the highlights of their well-established program.  

Transplant services offered at U of M include adult and pediatric deceased donor and living donor liver transplants, combined liver-kidney and heart-kidney transplants, and a heart-liver transplant program is in the planning stages.  Dr. Seth Wait is the Director of liver transplant surgery program.

The adult liver team consists of ten dedicated anesthesia faculty members and a consistent and strong liver anesthesiology fellowship program led by Dr. Sean Ewing.  The fellowship has seen an increasing number of external and internal interested candidates, currently with two fellows, including one pursuing a T-32 research track over a two-year period.

 The University of Michigan Liver Transplant Program is at the forefront of research and innovation including being the home to multicenter perioperative outcome research and driving clinical trials and studies in liver and kidney transplantation.  Currently over 90% of cases utilize normothermic perfusion devices, significantly increasing transplant volumes.  Other innovative initiatives include the Rapid Review and Sub-MELD15 Club, Led by Dr. Waits.  This initiative helps risk-stratify and accept expedited offers for suitable candidates.  They have a unique and focused Liver Transplant Perioperative Cardiac Risk Committee, which is multidisciplinary including anesthesiology, hepatology, transplant surgery, and cardiology experts working to mitigate cardiovascular risks in high-risk transplant recipients.  In this group exists a Dedicated Transplant Cardiologist, Dr. Nicole Bhave, who quarterbacks risk stratification for solid organ transplant recipients.

Looking ahead, as the program continues to grow, the University of Michigan Liver Transplant Program is on track to perform its highest transplant volume in program history.  They remain committed to providing exceptional care, advancing research, and training the next generation of transplant specialists with a commitment to excellence in patient care, research, and education driving success.  Clearly it’s not all football in Ann Arbor and hats off to the great team at Michigan!

Many thanks to Dr. Kumar for sharing details of their program.  If interested in having your program highlighted in the future, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

The Research Corner

By Michael Trostler, MD

Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis. By Ramirez-Cadiz Et Al.

This narrative review of the natural history of alcoholic hepatitis (AH) finds that mortality for alcoholic cirrhosis was decreased with earlier liver transplant.  Early transplant without a 6 month period of abstinence from alcohol should be considered as patients with AH may not survive their initial illness, and if they do survive often don’t recover liver function.

Effect of Dexmedetomidine on the Incidence of Postoperative Acute Kidney Injury in Living Donor Liver Transplantation Recipients: A Randomized Controlled Trial by Kwon et al.

Double Blinded RCT performed in South Korea of 205 patients examining the effects of dexmedetomidine (PrecedexⒸ) on the effect of AKI on patients receiving living donor liver transplantation (LDLT).  Results were encouraging with 35% of the study group having AKI and 50% of the control group.  Lactate levels were also significantly lower in the study group.  The potential to reduce ischemia-reperfusion injury during liver transplant hold great clinical importance to morbidity and mortality, this may be one component moving forward to alleviate some of the burden.

Universal intraoperative systemic heparin administration during liver transplantation: A case series By Diaz et al. 

This retrospective review at University of Michigan evaluates a change in practice of giving IV heparin prior to portal venous cross-clamp to only selected patients vs all patients. The study only had an incidence of intracardiac thrombus of 1.6%, it may be as high as 5-10%.  While the study did not have the power to see a statistical decrease in thrombotic events they did find that total blood product usage did not increase with increasing doses of heparin, and that there wasn’t a higher incidence of bleeding complications.  This study suggests that routine use of intraoperative heparin is safe, but notes that further research is needed to find the optimal dose.

Special Topics
By Alex Stoker, MD

Imaging piggyback outflow anastomosis with TEE during orthotopic liver transplantation

Sufficient venous outflow from a transplanted liver is necessary to ensure optimized perfusion pressure and for long term allograft survival. Stenotic piggyback anastomosis results in poor venous outflow and can lead to not only hemodynamic instability due to decreased right ventricular preload but also poor allograft function due to venous congestion. Transesophageal echocardiography (TEE) may be used to visualize the liver outflow anastomosis. Typically, the piggyback anastomosis can be imaged by advancing the TEE probe from the midesophageal bicaval view to image the IVC at the level of hepatic veins. Increasing the omniplane angle anywhere from 30-90 degrees may be necessary to fully visualize the piggyback anastomosis (see figure below). In the case of piggyback anastomosis stenosis, color flow Doppler will reveal flow acceleration with a high velocity and turbulent jet originating at the level of stenosis. It is important to recognize that some flow acceleration may be seen across the anastomosis in the absence of clinically significant stenosis due to a high cardiac output state and hyperdynamic circulation. There is increasing use of TEE to evaluate hepatic and IVC vasculature during liver transplantation and should be considered when venous outflow concern arises (Khurmi et al, 2019).

Reference:
https://pubmed.ncbi.nlm.nih.gov/31321114/

Figure. TEE image with and without color flow Doppler, demonstrating a widely patent piggyback anastomosis after reperfusion of the liver allograft. TEE view obtained by advancing the probe from midesophageal bicaval view to the level of hepatic veins. IVC, inferior vena cava. 

SATA Committee and Leadership Updates

The SATA Fellowship Committee – under the leadership of Dr. Ramona Nicolau-Raducu, has been actively involved in various educational initiatives, including a well-received fellow lecture series. Current projects include collaboration with the International Liver Transplant Society on developing guidelines for liver transplant anesthesia fellowships and cultivating networking opportunities for fellows, including planning social events at upcoming liver transplant anesthesia meetings. Our committee contributes to a comprehensive list of liver transplant anesthesia fellows and their directors, and we are committed to enhancing educational programs for fellows. We also continue to work with the Vanguard Committee to connect fellows with speaking opportunities and involve fellows in research presentations at SATA regional meetings. By Christine Nguyen-Buckley, MD

The SATA Membership Committee – was initially responsible for establishing the SATA membership list and membership communications. After this foundational work, we have been able to grow SATA with the expert support of PACA, our management company. While PACA now handles day-to-day membership operations, the SATA Membership Committee remains dedicated to addressing any member concerns. We are committed to both recruiting new members and retaining our valued current members. Our past initiatives have been aimed at enhancing the value of SATA membership. We also continue to partner closely with other committees such as the Vanguard and Fellowship committees. We invite you to share your thoughts on how we can further enhance the SATA membership experience by reaching out to us at sata@pacainc.com.  By Christine Nguyen-Buckley, MD

Abdominal Transplant Committee – for SATA has been quite busy over the past 3 years. We are excited to share that we have published two white papers in Clinical Transplantation. “Regional Anesthesia for Transplantation Surgery – A White Paper Part 1: Thoracic Transplantation Surgery” was published in June 2023. The subsequent installment entitled, “Regional Anesthesia for Transplantation Surgery – A White Paper Part 2: Abdominal Transplantation Surgery” was published in January 2024.

Since this recent success, the members of the ATC have started work on two new projects. We are currently in the literature review stage for a planned review paper covering machine perfusion in liver transplantation surgeries. The group is also in the beginning stages of a survey-based project that will poll anesthesia liver transplant directors regarding the use of regional anesthesia in the perioperative setting of liver transplantation surgeries.

The ATC hopes to attract additional SATA members who provide care for abdominal transplantation patients at their home institutions. We are looking for members who have an interest in research as well as further refining anesthesia care in the field of abdominal transplantation surgeries. If interested in joining SATA’s Abdominal Transplant Committee, please reach out to any ATC members. By Michael Ander, MD

SATA Seed Grant Application

We invite you to submit your application for the 2025 Seed Grant! The SATA Seed Grant is a one-year, $5,000 starter grant for transplant projects, open to junior faculty members and trainee physicians (residents and fellows). This grant aims to inspire and assist aspiring faculty/trainee physicians in initiating a transplant-related research project. It is specifically intended for projects that have not previously received extramural / non-departmental funding. Recipients must have sufficient departmental support to complete the project within one year. 

Application/Grant Cycle Timeline

Eligibility Requirements
Applicants must: 

• Be a current member of the SATA.
• Have received no prior extramural (“outside”) research funding for this specific project.
• Be a trainee (resident/fellow) with dedicated research time or faculty within ten years of their first appointment.
• Present an original project idea.
• Name a mentor and submit a mentoring plan (only required for Trainees and Faculty within three years of their initial appointment)
• Have the full support of the Department Chair, who must sign off on the grant application if awarded.
• Have the full support of the Program Director if the applicant is a trainee. 
• Submit a budget plan. This grant does not cover overhead or salaries, as it is a starter grant. While the SATA Seed Grant cannot be applied to salary support, it can be used to support costs for professional services from salaried professionals that are essential for the planning or execution of the project (e.g., statistician fees).
• Agree to present the completed study (or a progress report) at the SATA National Meeting following the award, including a financial report detailing how the grant was used.
• When submitting a manuscript to a peer-reviewed journal for publication, the investigators must acknowledge SATA Seed Grant funding.

 
Application requirements, instructions, and process. 

The grant application must include the following and must be submitted to sata@pacainc.com:

Phase 1: 

• Letter of Intent 

To include:

1. Project Title 
2. Name of the Investigator & Mentor
3. Description of the Proposed Research (500-word limit).
   Structure:
   • Background & Significance (2 paragraphs)
   • Specific Aim (1 paragraph)
   • Methods (1-2 paragraphs)

• Applicant Biosketch
  • (NIH Biosketch), including a personal statement tailored to this application.

Phase 2: 

The SATA Research Committee will select three submissions and invite the three applicants to submit a complete application & a 5-minute recorded presentation of their planned research.

Additional Documents for Phase 2:

1. Detailed project plan
   To include Objective, Background, Hypothesis, Aims, Methods and Materials, Timeline, Pitfalls, Solutions, Significance, and References. (2 pages + references)
2. Mentor Biosketch
   (A mentor is required if the PI is a trainee or a junior faculty member – within three years of their initial appointment)
3. Budget and Budget Justification
   Please note: the grant does not cover overhead or investigator salaries. (1 page)
4. Mentoring plan
   A mentoring plan, written by the mentor, is required if the PI is a trainee or a junior faculty member – within three years of their initial appointment (1 page)
5. Letter of support and commitment
   From the Mentor (if the PI is a trainee or a junior faculty member – within three years of their faculty appointment) or the Department Chair (for faculty members starting in the 4th year of their appointment) (1 page)

Selection Process

The review process will consist of two phases: The SATA Research Committee & SATA Council will review all letters of intent (Phase 1). Three investigators will be invited to submit a full proposal (Phase 2). One grant will be awarded per year.

Reporting and Award Requirements

Awardees must submit two progress reports six months and one year after the receipt of the grant:

The 6-month report should be brief (less than two pages) and include:

• Progress made to date (including expenses).
• Difficulties encountered or anticipated roadblocks and plans to mitigate them.
• Identification and explanation of any changes made from the original proposal.
• The committee will review the progress report and help resolve problems that arise to ensure the success of the grant recipient.

 
The 1-year report must be provided for review 13 months after the beginning of the Grant Period. The report will include:

• A summary of the objective and the results of the study,
• Any changes in the research project or mentorship,
• Publication or abstracts that have been generated from the study,
• A financial report detailing how the grant money was spent,
• Award of further funding.

The grant will be awarded to the grant recipient’s institution. All expenses funded by the grant are to be paid by the institution. Any unused funds are to be returned to SATA. The SATA and its auditors reserve the right to receive documentation and itemized expense receipts upon request.

Please address your questions regarding the application process to Dr. Dieter Adelmann (Chair of the SATA Research Committee) at dieter.adelmann@ucsf.edu.

For administrative questions, please reach out to the SATA Office at sata@pacainc.com.

Upcoming Events and Meetings

SATA Meetings:

SATA Southeastern Meeting, Virtual

Saturday November 16, 2024

SATA West Annual Meeting, San Francisco, CA 

Saturday December 14th, 2024

The 2025 Symposium for the Society for the Advancement of Transplant Anesthesia 

SATA Annual Meeting, Honolulu, HI

Monday March 23, 2024

(In conjunction with the IARS Annual Meeting)

More information coming soon!

Other Meetings:

KoreAnesthesia, Korean Society of Anesthesiologists Annual Meeting

November 7-9, 2024, Incheon, Korea

The Liver Meeting, The American Association for the Study of Liver Disease (AASLD)

San Diego, CA, November 15, 2024

The International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting

Boston, MA, April 27-30

UNOS Transplant Management Forum

San Antonia, TX, May 5-7, 2025

The International Liver Transplant Society (ILTS) Annual Congress

Singapore, May 28-31, 2025

SATA BOARD OF DIRECTORS: TERM  2023 – 2024

President
Gebhard Wagener, MD

Immediate Past President
Tetsuro Sakai, MD, PhD, MHA, FASA

Founding President
Ernesto A. Pretto Jr., MD, MPH

President-elect
Lorenzo De Marchi, MD

Secretary
Jiapeng Huang, MD, PhD, FASA, FASE 

Treasurer
Ranjit Deshpande, MBBS 

Executive Council

Michael Ander, MD, FASA

Adrian Hendrickse, BM, MMEd, MAcadMEd, FRCA

Sathish S. Kumar, MD

Raymond M. Planinsic, MD, FASA

Newsletter Editor-in-Chief
David Rosenfeld, MD, FASA

Newsletter Editorial Board

Sennaraj Balasubramanian, MD

Amit Bardia, MD

Andrew Gorlin, MD

Jiapeng Huang, MD, PhD, FASA, FASE

1. Susan Mandell, MD, PhD

Sergio Navarrete, DO

Yong G Peng MD, PhD

Alexandra Ruan, MD

Flora Simmons, MD

Natalie Smith, MD

Alex Stoker, MD

Michael Trostler MS, MD

UNOS News

By Flora Simmons, MD

Record-breaking 10,000 Liver Transplants Performed in 2023

In 2023, more than 10,000 liver transplants were recorded, more than any single year in history. This continues the eleven-year streak of record-breaking numbers of liver transplants. More changes to liver allocation are coming soon and should continue to increase annual liver transplant numbers. Link Here

Changes to Minimum Donor Criteria for Kidney Biopsies Leads to increased Kidney Donors

A policy change aiming to standardize biopsy practices was implemented on September 22, 2023 to help improve kidney allocation efficiency. The policy establishes minimum donor criteria for kidney biopsies. The most recent monitoring report shows a six percent (6,930) increase in deceased kidney donors recovered. Link Here

New pre-transplant performance metric

A new risk-adjusted performance monitoring metric will take effect in July 2024 called the “pre-transplant mortality rate ratio”. The pre-transplant mortality rate ratio indicates whether patients listed at a program are more or less likely to die prior to receiving a transplant than expected. Link Here

Change to the Organ Offer Acceptance Limit

On May 29, 2024 the number of offers a transplant hospital may accept per transplant candidate will be reduced. Link Here

Research Updates and Interesting Articles

By Michael Trostler, MD and Alex Stoker MD

Perioperative Considerations in Older Kidney and Liver Transplant Recipients: A Review

The aging population has led to an increase in the ages of our transplant population. This narrative review details the individual factors that aging patients deal with and should be recognized as we proceed with transplanting this patients. Frailty, sarcopenia, cognitive dysfunction, likelihood of malignancy, coronary artery disease and associated disorders are some of the preoperative factors that we need to be considering. Link Here

Understanding Alcohol Relapse in Liver Transplant Patients With Alcohol- Related Liver Disease: A Comprehensive Review

Alcoholic relapse is a formidable challenge in alcohol related liver disease and liver transplant. This review explores the nature of relapse and strategies to prevent it. This is written with alcoholic cirrhosis in mind, but the strategies are equally relevant in acute alcoholic hepatitis as these patients have not had a period of abstinence prior to transplant. A holistic approach, recognizing the interconnections between the social, psychological, medical, and physiological factors are key to preventing relapse. Link Here

Liver Machine Perfusion Technology: Expanding the Donor Pool to Improve Access to Liver Transplantation

The effect of machine perfusion on liver transplant center donor utilization. Significantly more DCD donors were used, increased DCD >50 years old, increased steatosis fraction utilization, and increased warm ischemia time. Link Here

Universal Antifungal Prophylaxis Effectively Prevents Fungal Bloodstream Infection in Pediatric Liver Transplant Recipients: A retrospective real-world study

Empiric treatment of pediatric liver transplant recipients with anti-fungals helped prevent fungal bloodstream infections in a retrospective study of 604 pediatric liver transplant recipients in China. Link Here

Perioperative Cardiovascular Risk Assessment and Management in Liver Transplant Recipients: A Review of the Literature Merging Guidelines and Interventions

Liver transplant is the second most common solid organ transplant procedure worldwide, as increasing numbers of transplants are performed each year and as the age of transplant recipients increases screening for CAD is especially important. This literature review covers risk stratification techniques/tests, transplantation. Link Here

Outcomes following concomitant multiorgan heart transplantation from circulatory death donors: The United States experience

The recent emergence of ex-vivo machine perfusion and normothermic regional perfusion has allowed for expansion of the donor heart pool by utilization of Donation after circulatory death (DCD) organs. Multi-organ heart transplant candidates face a high waitlist mortality. Outcomes following multi-organ heart transplantation from DCD donors is not well established, as these patients had been excluded in recent RCTs of DCD heart transplantation.

In this retrospective study of multiorgan heart transplant candidates and recipients, the authors found willingness to consider DCD offers was associated with higher likelihood of transplant for all multiorgan heart candidates. Heart- kidney recipients of DCD organs had similar post-transplant outcomes compared to recipients of brain-dead donor transplants. While heart-liver and heart-lung recipients represented a group too small for analysis, all patients were alive at last follow up. Link Here

Update from the SATA Council Meeting and National Meeting in Seattle

By Jiapeng Huang, MD, PhD and David Rosenfeld, MD, FASA

SATA Executive Council met in person in Seattle on May 19-20, 2024. The Council discussed plans to develop strategic plans for the coming years.

Discussion points included streamlining SATA committees to avoid overlap and redundancies. In addition, SATA is working closely with ILTS on the upcoming SATA/ILTS perioperative meeting in Philadelphia in Oct 2024. Agenda and speakers are being finalized. SATA has initiated the official application process to become an ASA subspecialty society, which will create significant alignment, collaboration and synergy between SATA and ASA. SATA is also working very closely with our industrial sponsors to promote transplant anesthesiologists recruitment and education.

The SATA National Symposium in Seattle was a resounding success and attended by over 50 physicians . We had great presentations including a section from colleagues from the Korean Society of Transplant Anesthesiologists (KSTA). Pictured below is Dr. Gebhard Wagener with Dr. Sang-Hyun Kim from Soon Chun Hyang University Medical Center during the speakers dinner. We also had a great experience with the first POCUS/TEE Interactive Training Workshop.

Special Topics

By Alex Stoker, MD

Lipomatous Hypertrophy of the Interatrial Septum

Lipomatous hypertrophy of the interatrial septum (LHIS) is a benign cardiac lesion characterized by fat accumulation in the interatrial septum with a prevalence between 2.2% and 8% and can be diagnosed by computed tomography, cardiac MRI as well as transesophageal echocardiography (TEE). Using TEE, LHIS is best seen in the midesophageal bicaval view and typically involves hypertrophy of both the cephalad and caudal portions of the interatrial septum, projecting into the right atrium and sparing of the fossa ovalis, creating the classic “dumbbell” shape (see Fig 1 below). Criteria for LHIS includes an atrial septum thickness greater than 2 cm. LHIS can predispose patients to atrial arrhythmias due to conduction disturbances from fat infiltration as well as inflammation. LHIS is associated with advanced age, obesity and pulmonary emphysema. It is important to recognize LHIS as this can be mistaken for other pathology such as malignant cardiac tumors or even intracardiac thrombus.

Link Here

In the Spotlight: University of California – Los Angeles – Abdominal Organ Transplant Program

By David Rosenfeld, MD, FASA

For the spring newsletter we are highlighting UCLAs Abdominal Organ Transplant Program. The program is based out of the Ronald Reagan UCLA Medical Center which was opened in 2008 and is a 520-bed center of over a million square feet. This historic liver transplant program was launched and grown under the leadership of renowned surgeon Ronald Busittil in 1984. The abdominal transplant program currently includes both adult and pediatric liver, small bowel and multivisceral transplants. The pediatric arm is staffed by pediatric anesthesia physicians under the UCLA Mattel Children’s Hospital umbrella within the Reagan UCLA footprint. Renal transplantation is managed under the Department of Urology. Volume data from 2023: 195 Liver Transplants, 8 Pediatric LT, 1 Small Bowel.

The adult team includes eleven attending anesthesiologists, as well as a separate pediatric team for that arm. At all times two attendings are on call for the liver team. This team also covers hepatocellular carcinoma resections, hepatic metastatic cancers, complex Whipple procedures and invasive renal cell carcinoma surgeries. UCLA’s patient population is high acuity with an average MELD-Na of 34, with a high percentage of ICU patients listed. Cases are mixed between total cava exclusion (60%), piggyback (25%), and veno- veno bypass (5%) depending on the surgeon and anatomy, with ROTEM and TEE frequently used, and CRRT common. Anesthesiologists are a consistent member of the selection committee, with surgeons, cardiologists, pulmonology

rounds with the entire team. The anesthesiology division meets monthly with case discussions, QI reviews, preoperative evaluations, research presentations, with minutes distributed.

UCLA has a large anesthesiology residency of 27 per class. An intense two- week experience in liver transplant is combined with a two weeks of vascular in a one month rotation. Extensive LT anesthesia website educational resources, simulation-based LT resident training model, and an extensive reading list and Powerpoint lectures are offered. UCLA has a one year non-ACGME Liver Transplant Anesthesia Fellowship for up to two candidates with the goal of training the fellow to be a perioperative consultant in liver transplant anesthesia. Fellows spend 50% of time in clinical liver transplant anesthesia and 50% time working as a staff anesthesiologist. Salary reflects this blended role with additional ability to moonlight. Fellows receive training in transesophageal echocardiography with experience geared towards the Basic PTEXAM Examination of Special Competence. Research experience is encouraged. The division’s research arm is robust with ongoing prospective and retrospective investigations and an institutional outcome database collected for over 20 years. Collaborations exist with cardiology, liver transplant surgery and critical care, and other institutions. Special thanks to Fellowship Director Dr. Christine Ngyen-Buckley, and Service Chief Dr. Christopher Wray for their contributions to this section. If you have interest in having your program highlighted in the future, please contact me at Rosenfeld.david@mayo.edu

SATA Member Corner: 5 minutes with Dr. Christine Nguyen-Buckley from UCLA

By Alex Ruan, MD

Can you share a little bit about your background and your journey to a career in medicine?

My first job out of college was as a study coordinator in pediatric infectious diseases. I realized during that job that I really wanted to work with patients and take care of them as a physician. So that’s what drove me to going into medicine. For anesthesiology, I didn’t really have a good idea of what it was about, even though my husband is an anesthesiologist. During my surgery rotation, the anesthesiologist asked me to come to the head of the bed and let me participate in the patient’s care. He let me do minor things like holding the

thought, “Oh, wow! Look at all these things the anesthesiologist gets to do.” Why transplant anesthesiology?

Transplant anesthesia can be exciting and gratifying. It feels so good when you see patients you care for go from the extremes of being sick in the ICU to recovering after transplant. It’s gratifying when patients come back for routine outpatient procedures like colonoscopies and they look so well. I also have a nice mix of cases in my practice – some days I’ll do general routine cases, then other days, I’m dealing with the intensity of getting someone safely through a transplant.

Why did you join SATA? How long have you been a member of SATA and what is your current involvement with the organization?

I’ve been a member of SATA since around the time that I was a fellow. I’m trying to remember the details, but at the ASA, I think Ryan Chadha said to me “Hey, there’s this SATA meeting. Do you want to check this out?” And so I went to it. There were all these big-time transplant anesthesiologists that were there. It was very intimate and a small group at that point. And now it’s grown so much. It has been really great to be part of an organization where it has been so easy to get involved, even as a fellow.

I’m currently the chair of the SATA membership committee. I would like to help people be satisfied with their experience as SATA members, and then also to recruit members and get them involved. SATA needs the help of its members! Members can email me and I can help connect them to people in areas they may be interested in.

What are your research interests, and do you currently have any research/ clinical projects going on?

My research interests involve perioperative care of liver transplant patients. We’ve been looking at complications like intracardiac thrombosis, how to prevent and treat it, but also why it happens. I’m also interested in education in liver transplant, particularly liver transplant fellowship.

What is your favorite piece of anesthesia equipment?

How do I even choose – it’s so hard to pick a favorite! But one piece of anesthesia equipment that I used today that I was so grateful for, and just love, is having point of care testing in the OR. You can get a blood sample and then almost immediately get the patient’s glucose, hemoglobin, a blood gas, electrolytes and then repeat that as often as you need to. This allows you to do this independently and not be reliant on someone to take it to the lab, then for the lab to run it, so that you can really manage your patient very closely. I find it really crucial, not only for liver transplant anesthesia where we are getting labs every hour or even more often, but general cases as well.

What do you enjoy doing outside of work?

I have 3 sons, they’re 11, 8 and 2. So that keeps me pretty busy. But I also like traveling, I like the outdoors, I like reading a lot – anything from like psychological thrillers and true crime novels to the New York Times.

What advice would you give to a medical student or resident who is interested in liver transplants?

I would say they should definitely join SATA. We have a discounted rate for trainees, and it’s a fantastic opportunity to learn about liver transplant anesthesia and to meet and work with experts in the field. SATA has been very helpful for me in my career by helping me make connections for research projects. Medical students and residents should join the Vanguard Committee so they can get involved and further their career.

Dr. Nguyen-Buckley can be reached at cnguyenbuckley@mednet.ucla.edu.

If you or someone you know is interested in being featured in the SATA newsletter, please reach out to Dr. Alexandra Ruan aruan@stanford.edu

Newsletter Committee Update

Future ideas – we are exploring the concept of having a printed newsletter to serve our membership. The SATA newsletter committee is actively seeking

new members. Those interested in all topics related to transplant anesthesia are welcome. We are always looking to expand ideas and content for the newsletter. If interested, please contact David Rosenfeld, MD at Rosenfeld.David@mayo.edu

SATA Survey

Adult Liver Transplant Anesthesiology Practice in the Post-COVID-19 Era: Survey from the Society for the Advancement of Transplant Anesthesia

We previously sent out an email about participating in the first survey from the SATA Practice Management Committee focusing on adult liver transplant institutions in the United States. This is a reminder email to please complete the survey if you have not previously. The link is below, we greatly appreciate your time and effort to share your experience. If you

Ted Sakai (sakait@upmc.edu).

Follow this link to the Survey:

Take the Survey

Or copy and paste the URL below into your internet browser:

https://ucdenver.co1.qualtrics.com/jfe/form/SV_9piQkrlQ5YnJ3iC? Q_DL=8SwUYTYkHyJIGtG_9piQkrlQ5YnJ3iC_CGC_Wc4OqWtC9OalYgm&Q_ CHL=email

Future SATA Events and Meetings

SATA Mid State Meeting – September 27th, Virtual

SATA/ILTS Perioperative Meeting – With the ASA National Meeting, October 18, Philadelphia, PA

SATA Winter West Coast Meeting – December 14, 2024, UCSF

Transplantation Upcoming Meetings

American Transplant Congress, June 1-5, Philadelphia, PA Link Here

30th International Congress of The Transplantation Society (TTS 2024) – TTS Official Meeting, September 22-25, Istanbul, Turkey. Home (tts2024.org)

13th Congress of the International Pediatric Transplant Association (IPTA 2025)

– TTS Official Section Meeting, September 18 – 21, Berlin, Germany

18th Congress of the International Xenotransplantation Association (IXA 2025) – TTS Official Section Meeting, Sept 30-October 3, Geneva Switzerland. Link Here

BOARD OF DIRECTORS: TERM 2023 – 2024

President

Gebhard Wagener, MD

Immediate Past President

Tetsuro Sakai, MD, PhD, MHA, FASA

Founding President

Ernesto A. Pretto Jr., MD, MPH

President-elect

Lorenzo De Marchi, MD

Secretary

Jiapeng Huang, MD, PhD, FASA, FASE

Treasurer

Ranjit Deshpande, MBBS Executive Council Michael Ander, MD, FASA

Adrian Hendrickse, BM, MMEd, MAcadMEd, FRCA Sathish S. Kumar, MD

Raymond M. Planinsic, MD, FASA

Newsletter Editor-in-Chief

David Rosenfeld, MD

Newsletter Editorial Board

Sennaraj Balasubramanian, MD Amit Bardia, MD

Jiapeng Huang, MD, PhD, FASA, FASE

1. Susan Mandell, MD, PhD Sergio Navarrete, DO Yong G Peng MD, PhD Alexandra Ruan, MD

Flora Simmons, MD Natalie Smith, MD Alex Stoker, MD

Michael Trostler MS, MD

UNOS News

By Flora Simmons, MD

UNOS Launches National Liver Pairing Program

In an effort to increase access to living donations, UNOS has initiated a national pairing program for swapping livers.  While some transplant centers have swapped livers within their own hospitals, this program now allows swapping across the nation.  

Waiting Time Adjustment Approved For Kidney Transplant Candidates Affected By Race-based Calculation

After discontinuing race-based calculations for estimated glomerular filtration rate (eGFR), the new policy will now allow African-American kidney transplant candidates to receive waiting time modifications that will increase their waiting times and associated prioritization for transplant. 

National Collaboration To Increase DCD Lung Transplantation Underway

UNOS recently launched a national initiative to identify and share effective practices that can increase transplantation of DCD lungs. Twenty-nine lung transplant programs are participating in this project. 

Research Updates and Interesting Articles

By Michael Trostler, MD

• Validation of the Liver Transplant Risk Score in Europe

LTRS is a useful predictor of Mortality that has been validated in the United States, but not in Europe.  Based on the data the European registry collects, the score has been modified to exclude Diabetes.  Age, BMI, MELD score, and Dialysis status were used with linear correlation for 90-day and 1-year mortality for each point.  Included 2nd article external validation of LTRS in US (2020).

Validation of the Liver Transplant Risk Score in Europe.pdf

Preoperative Stratification of Liver Transplant Recipients- Validation of LTRS.pdf

• Anesthesia Management of a Liver Transplant Recipient with Remimazolam

Case report of a 54 year old Female who had a prolonged living donor liver transplant (1037 min) and massive blood loss (22.5L) who was successfully managed with Remimazolam without recall or adverse events with EEG monitoring.

Anesthesia Management of a Liver Transplant Recipient with Remimazolam.pdf

• Survival Benefit of Living-Donor Liver Transplant

Large epidemiological study on 119,275 Liver transplant patients, with 2,820 living donor transplants which found a 13-17 year life gain for those who received a liver donor transplant for MELD>11, compared to those who stayed on the waiting list.  This article generated significant interest with several comments/letters and the original authors reply which are well worth your time to read.

Survival Benefit of Living Donor Liver Transplant.pdf

Reply to Survival Benefit of Living Donor Liver Transplant 1.pdf

Reply to Survival Benefit of Living Donor Liver Transplant 2.pdf

Reply to Survival Benefit of Living Donor Liver Transplant 3.pdf.

• Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score

An updated review article of end stage liver disease scoring systems and their inherent weaknesses.  The future may be artificial intelligence, but its predictive algorithms can be individualized and may not be applicable to the wider population outside of each study cohort.

Mortality scoring systems for liver transplant recipients- before and after model for end stage liver disease score.pdf

• Comprehensive quality initiative leads to immediate postoperative extubation following liver transplant

A concerted push via QA/QI project achieves safety and success for immediate extubation of liver transplant recipients in both low risk and high risk patients.  There was no change in mortality and only four(1.26%) patients were reintubated within 24 hours (Total 317 patients).  Quality initiative pushes immediate extubations from 13.4% to 86.7% over a five year period. 

Comprehensive Quality initiative leads to immediate postoperative extubation following liver transplant.pdf

Special Topics

By Alex Stoker, MD

IVC stenosis during liver transplant detected with TEE

Acute inferior vena cava (IVC) stenosis after liver transplantation is a rare but significant complication that can result in liver allograft congestion and dysfunction as well as hemodynamic instability. Transesophageal echocardiography (TEE) may be used to diagnose IVC stenosis, which may reveal a high velocity or turbulent jet entering the right atrium from the IVC as detected with color flow Doppler (CFD) (see figure below). By interrogating the IVC, it may be possible to visualize the area of narrowing within the IVC, with CFD revealing flow acceleration and turbulent flow originating at the level of stenosis. Obstruction may occur in the suprahepatic IVC, infrahepatic IVC or hepatic veins and can be due to surgical complication or due to thrombosis. There is increasing use of TEE to evaluate hepatic and IVC vasculature during liver transplantation (Khurmi et al, 2019). Reference

Midesophageal bicaval view with color compare showing the image both with and without color flow Doppler. A turbulent and high velocity jet is seen entering the right atrium from the IVC due to IVC stenosis. LA, left atrium; RA, right atrium; IVC, inferior vena cava; SVC, superior vena cava.

2022 UNOS Organ Transplant Summary

By Alexandra Ruan, MD

https://unos.org/news/2022-organ-transplants-again-set-annual-records/

• More than 42,800 organ transplants performed in 2022, a 3.7% increase from 2021
• Total kidney transplants exceeded 25,000 for the first year ever
• Annual records also set for liver (9,528), heart (4,111) and lung (2,692) transplants
• Over 6,400 living donor transplants
• Deceased donation increased for 12th consecutive year
• The U.S. has now performed over 1 million transplants

In the Spotlight:  Virginia Commonwealth University (VCU) Health System – Hume/Lee Transplant Center

By David Rosenfeld, MD, FASA

For this winter’s section we reached out to Spencer Liebman, MD, who is Chief, Division of Transplant Anesthesiology at VCU. Formerly known as Medical College of Virginia, VCU is an 820 bed health system and one of the nation’s first transplant programs.  This historic program is named for David M. Hume, MD and Hyung Mo Lee, MD, and is where one of the earliest identical twin kidney transplants was performed in 1957, with the overall program starting in 1962.  Soon after livers began in 1964, with the world’s 16th heart transplant in 1968.  The scope of organs includes livers, kidneys, pancreas, and hearts, with experience in combined heart-liver transplant.  A total of 502 organs were transplanted in 2022. 

VCU offers 112 ICU beds, 16 of which are cardiac, and a dedicated transplant ICU growing to 10 beds under the direction of Megan Rashid, MD.  The liver practice is large with 168 total adult organs, 21 of which were from living donors.  Staffing is in a team care model with five dedicated attendings, six specially trained CRNAs, and residents rotating in their CA2/CA3 years.  TEG is universal, and TEE is utilized for greater than 80% of cases.  As is becoming more common, intraoperative hemodialysis (not CRRT) was used in 40% of cases in 2022.  They offer a unique Active Severe Alcoholic Hepatitis Transplant Program with support services and strategies in place.  VCU has a non-ACGME liver fellowship with a hybrid model of combined fellow and faculty time and two positions per year.  In 2016 the Total Pancreatectomy with Islet Cell Autotransplant (TPIAT) program was started with the addition of Transplant Surgeon Marlon Levy, MD to the faculty.  A total of 18 TPIATs were performed in 2022 for chronic pancreatitis, and they are one of the few centers offering this experimental therapy.  Their cardiac program is the longest running on the east coast and the second oldest in the US.  Over 680 heart transplants have been performed, and they offer an ACGME accredited Adult Cardiothoracic Anesthesiology fellowship with two fellows per year.  There are no lung transplants being performed at present.

Many thanks to Dr. Liebman for sharing details of the transplantation program at VCU.  If interested in having your program highlighted in the future, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

*The original newsletter identified VCU as performing the first identical twin kidney transplant in 1957.  This was in error, the first kidney transplant was performed in an identical twin by Dr Joseph E.Murray in Boston in 1954.  Correction made above.   

Report from the Executive Council

By Susan Mandell, MD

We look forward to seeing SATA members at the in person SATA National Meeting, held at the IARS on April 17th, 2023, in Denver Colorado.  Please remember to renew your membership for free entry to the meeting.  SATA is pleased to announce it will hold the first combined meeting with the International Liver Transplant Society-SATA meeting  just prior to the ASA in San Francisco. This has been a very popular meeting and well attended. 

The Council is pleased to announce that there are now seven regional SATA meetings.  Please check for the meeting closest to you.  Service on the SATA Accessibility and Diversity Committee is now open to all members.  The Vanguard committee has been revitalized and membership is open to all faculty who are within 5 years of residency completion or are younger than 42, please reach out to the SATA Office for more information.   

Announcements

We are pleased to announce that SATA will be represented at the 10th Annual Korean Society of Transplant Anesthesiologists (KSTA) meeting in Seoul, Korea. During the Joint KSTA-SATA session (March 18, 2023 11:20-12:50 KST), moderated by Dr. Tetsuro Sakai and Justin Sangwook Ko, Dr. Satish Kumar will present on emerging evidence for coronary artery disease screening in liver transplant candidates and Dr. Ramona Nicolau-Raducu will present on post-reperfusion hyperfibrinolysis.  

SATA is delighted to endorse the first International Symposium for Abdominal Organ Transplant (ISAOT) in Santiago, Chile, June 8-9, 2023. 

This opportunity is presented by Dr. Klaus Torp at Mayo Clinic-Jacksonville (Founding member of SATA) who has supported the physician exchange program with the Clinica Alemanha in Santiago de Chile. Dr. Lucile Gignon (Faculty Anesthesiologist at the Clinica Alemanha in Santiago de Chile) is the local organizer of the meeting.

Attention liver transplant anesthesiologists and program directors!  SATA is offering free 6 month membership to fellows!  Please sign up by emailing sata@pacainc.com. We look forward to welcoming new fellow members!

Join the Vanguard Committee ***

Transplant Anesthesia Upcoming Meetings

SATA Meetings

SATA Tristate Regional Meeting – in person and virtual

March 25th, 2023, New York, NY

SATA Annual Meeting, 

April 17th, 2023, Denver, CO

Other Meetings: 

The 10th annual scientific meeting of the Korean Society of Transplantation Anesthesiologists (KSTA), March 18th, Seoul, Korea – in person and hybrid

Joint KSTA-SATA Session: 11:20 – 12:50 KST

IARS/AUA/SOCCA Annual Meeting – in person and hybrid

April 13-16th, 2023, Denver, CO

The 2023 International Congress of ILTS, ELITA and LICAGE

May 3-6, 2023; Rotterdam, Netherlands

American Transplant Congress (ATC) 2023 Annual Meeting

June 3-7, 2023, San Diego, CA

International Symposium for Abdominal Organ Transplant (ISAOT)

June 8-9, 2023, Santiago, Chile

UNOS News

By Flora Simmons, MD

OPTN Board Eliminates Race-based Calculation For Transplant Listing

In a momentous measure to provide equitable access to all transplant candidates, the board of directors of the Organ Procurement and Transplantation Network recently approved a precedent requiring transplant hospitals to use race neutral calculations when estimating a candidate’s glomerular filtration rate (GFR).  Read more here.

Kidney Transplants have Increased in Minorities since Policy Changes 

Following implementation of the updated allocation system, one year monitoring reports show that transplant rates increased significantly for several key populations including Black, Hispanic, Asian, and pediatric candidates. The updated allocation system replaced the donation service area and administrative regions with a 250 nautical mile circle around the donor hospital. Read more here. 

Research Updates and Interesting Articles

By Michael Trostler, MD

“Abdominal Organ Transplantation: Noteworthy Literature in 2021”– Seminars in Cardiothoracic and Vascular Anesthesia

Highlights:  Yearly article by corresponding author, SATA president Dr. Tetsuro Sakai, selecting 20 articles from over 10,000 articles published over the year.  Read the article here

“Analysis of outcomes and renal recovery after adult living-donor liver transplantation among recipients with hepatorenal syndrome” – American Journal of Transplantation

Highlights:  Retrospective analysis of 2185 living donor liver transplants over a 7 year period found that time from HRS to transplant was significantly associated with recovery, and recovery was significantly associated with survival. Read the article here

“Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial” – American Journal of Transplantation

Highlights: Machine perfusion is at the forefront of new technological innovation in the transplant community.  A randomized control trial of HOPE in 110 extended criteria donors found improved outcomes with lower graft dysfunction and better graft survival. Read the article here

“Transplantation of a human liver following 3 days of ex situ normothermic preservation” – Nature Biotechnology

Highlights: 3 days of Ex-Vivo machine perfusion prior to transplant was successful and at one year follow-up the recipient was alive and the biliary tree intact.  Read the article for the amazing details here 

“Final Safety and Efficacy Results from a 106 Real-World Patients Registry with an Ascites-Mobilizing Pump” – Liver International

Highlights: 12 European centers have followed 106 patients over 24 months with a “Alfapump”, an intraperitoneal fluid management system that pumps ascites from the peritoneal cavity into the bladder for excretion.  Designed for those ineligible for a TIPS procedure. Read the article here

“Sequential liver and kidney living donors: Making the ultimate gift twice” – Clinical Transplantation

Highlights: 150 living donors in the United States have donated more than one organ.  20 of these donors donated at UPMC- Pittsburgh, with 70% non-directed/altruistic with first donation and 80% non-directed/altruistic at the second donation. Read the article here

Special Topics

By Alex Stoker, MD

Imminent Death Donation

Imminent death donation (IDD) is a proposed organ donation practice described as the recovery of a living donor organ immediately prior to an impending and planned withdrawal of ventilator support expected to result in the patient’s death [OPTN white paper, 2016]. This practice is aimed at increasing the availability of donated organs through increased utilization of organs from donors who may have had non-progression during attempted DCD donation and by reducing organ ischemia.  In 2016 the ethics committee of the Organ Procurement & Transplantation Network (OPTN) outlined several ethical concerns, potential risks, as well as challenges of IDD; however, acknowledged the possibility of overcoming those challenges in the future [OPTN white paper, 2016]. A recent survey by Washburn et al explored the public attitudes towards IDD in the United States and describe a scenario in which one kidney, a portion of liver and portion of lung are donated prior to withdrawal of life support [Washburn et al, 2020]. 

Read more from reference here

Rise of the Machines – Normothermic Ex Vivo Perfusion in Liver Transplantation 

Since the first use of normothermic machine perfusion (NMP) in human orthotopic liver transplantation in 2013 there has been considerable and growing interest in using NMP to improve organ quality prior to transplantation by maintaining the allograft in a physiologic state during transportation. While ongoing investigations have yet to confirm all the potential benefits, NMP may reduce allograft ischemic damage, lessen the metabolic and hemodynamic derangements following liver reperfusion, increase the utilization of marginal organs, improve transplant logistics and expand the donor pool.

Read more from reference here

Many thanks to Dr. Bottiger for sharing details of  the transplantation program at Duke University Medical Center.  If interested in having your program highlighted in the future, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

Announcements

Attention liver transplant anesthesiologists and program directors!  SATA will be offering free 6 month membership to fellows!  Please sign up by emailing sata@pacainc.com. We look forward to welcoming new fellow members!

Transplant Anesthesia Upcoming Meetings

SATA Meetings:

Midstate SATA Regional Meeting: September 24, 2022

Southern SATA regional Meeting: November 5, 2022 

Mid-Western SATA Regional Meeting: January 21, 2023

Other Meetings: 

ILTS Perioperative Care in Liver Transplantation Meeting 2022

October 21, 2022; Ochsner Health, LA; in-person and virtual

The 2023 International Congress of ILTS, ELITA and LICAGE

May 3-6, 2023; Rotterdam, Netherlands

American Transplant Congress (ATC) 2023 Annual Meeting

June 3-7, 2023, San Diego, CA

In the Transplant News:

Flora Simmons, MD

UNOS Updates

• ASTS Position Statement On The Role Of COVID-19 Vaccination For Transplant Candidates And Recipients: The American Society of Transplant Surgeons continues to recommend routine vaccination for all organ recipients (along with timely boosters). It also recommends vaccines for those on the waiting list, if possible. Read more at the ASTS Position Statement. 
• Kidney Transplants Increase Across All Populations Following Policy Changes: Changes to kidney allocation were made in March of this year with the goal of improving access to organs and equality. Recent data shows that kidney transplants for all age groups, blood types, CPRA, and diagnoses have increased following the implementation of these new policies.  Read more at the UNOS News Section. 
• Second Phase Of National DCD Procurement Collaborative Project Ready To Launch: UNOS has launched the second phase of a national collaborative improvement project to help organ procurement organizations (OPOs) identify and share effective practices related to recovery of donation after circulatory death (DCD) organs. Read more at the UNOS News Section.

In the Spotlight: The Miami Transplant Institute (MTI)

David Rosenfeld, MD

An affiliation between Jackson Health System and UHealth-the University of Miami Health System.

In this month’s feature we learn from Drs. Ramona Nicolau-Raducu and Yehuda Raveh some of the characteristics that are unique about MTI.  

The program is housed within the massive Jackson Memorial Hospital, one of the ten largest hospitals in the world with 2000 beds.   Year in and out they are amongst the busiest abdominal programs with a US leading 472 kidneys transplanted in 2020, including a paired exchange program.  MTI is also a front-runner in liver for the last 50 years, with over 4500 cases performed and 131 adult and 22 pediatric in 2020.  Pancreas transplant is equally robust.  For more than 20 years, and greater than 500 cases, a multidisciplinary team of experts at MTI has been treating thousands of children and adults with intestinal failure via Intestinal Rehabilitation or the Intestinal/Multivisceral Transplant Program, with outcomes well above national averages.  Along with deceased donor intestinal (~5 cases/year) and multivisceral transplants (~10-15 cases/year), autologous transplant procedures are offered.  

MTI became in recent years a bloodless center for Jehovah Witness transplants with a meticulous selection process for Jehovah’s Witness liver candidates.  A bloodless protocol has been established of using factor concentrates, hemopure (bovine hemoglobin-based oxygen carrying solution) autotransfusion and cell saver.

In February 2020 the national organ allocation system transformed from donor service area-based to an acuity circles-based model. Due to its unique geography near the tip of the Florida peninsula, the new system limits organ allocation.  As a result, use of DCD and other extended criteria grafts for liver or liver-kidney have increased, currently approximately 25% of liver grafts. In addition, patients listed for multivisceral transplantation are especially impacted by this change.  Due to specific quality requirements for suitable donors, which are typically younger and non-obese, the available donor pool is considerably smaller. Previously these patients were assigned amongst the highest status levels on the liver match run, but the current allocation model routinely prioritizes a suitable donor to a liver alone candidate that does not have the same size and quality limitations but has a high “competitive” MELD score.

The Abdominal Transplant Anesthesia Fellowship at Jackson Memorial Hospital was created in 2006 by Dr. Ernesto Pretto, Chief, Division of Transplant Anesthesia and is one of the largest in the nation with 4 fellows/year.  Transplant anesthesiology fellowships are non-ACGME accredited and are generally less popular for board eligible/certified US anesthesiology graduates, however this program has thrived through selecting highly qualified foreign graduates to consistently fill its positions.   They have graduated a remarkable 50 transplant fellows in the last 15 years (10% US graduates and 90% International).

Many thanks to Drs. Nicolau-Raducu and Yahuda for sharing details of their program. 

If interested in having your program highlighted, please contact David Rosenfeld, Mayo Clinic Arizona at Rosenfeld.david@mayo.edu

 Featured Publications in the Transplant Literature: 

Michael Trostler, MD

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size (Liang et al. BMC Surg. 2021) 

Since 1996 Milan criteria for hepatocellular carcinoma has been used to guide liver transplantation to those who would benefit most and restrict deceased donor organs to those with the highest likelihood of survival. Living donor transplants tend to be directed to individuals who do not meet this criteria if the donor and recipient understand the potential risk. Liang et al. out of Taiwan report on 155 patients, 78 of which were beyond Milan criteria for tumor size or number found similar outcomes and recurrence rates. They propose a new criteria: maximum tumor size <= 6cm and total tumor size < 10cm.

Challenges and opportunities for treating intrahepatic cholangiocarcinoma (Serifis et al. Hepat Med. 2021)

There is potential to expand transplant criteria for living donor liver transplantation with less stringent criteria for directed donors. In addition to the potential for an expanded hepatocellular carcinoma guideline, cholangiocarcinoma is another disease process with historically poor outcomes which may be treated by transplantation with strict selection criteria, operative staging, and neoadjuvant therapy. 

Liver transplant outcomes after ex vivo machine perfusion: A meta-analysis (Liew et al. Br J Surg. 2021)

Ex-vivo machine perfusion – Meta-analysis included 34 articles with odds ratios favoring hypothermic machine perfusion over static cold storage. Findings include: decreased early graft dysfunction, ischemic cholangiopathy, non-anastamotic strictures and graft loss. Machine perfusion was associated with shorter length of stay. Normothermic perfusion is associated with reduced graft injury. 

Machine perfusion organ preservation: Highlights from the American Transplant Congress 2021 (Pavan-Guimaraes et al. Artif Organs. 2021)

At the American Transplant Congress (June 2021) 33 abstracts on machine perfusion were presented including heart, lung, liver and kidney. Machine perfusion may become gold standard in the future as innovation and advancement bring down costs and improve outcomes. 

SATA Committee’s Update

Yong G Peng, MD, PhD

We caught up with the Quality and Standards Committee Chair, Dr. Adrian Hendrickse (Associate Professor, University of Colorado). The members of the committee have been working hard on several surveys. The first survey, led by Dr. Cara Crouch (Assistant Professor, University of Colorado), looked at Adult Liver Transplant Anesthesiology practice patterns across the US. Their research was published in the Journal of Clinical Transplantation. (Crouch et al. Clin Transplant. 2021)

Additionally, a smaller sub-committee of members are interested in living donor liver transplantation (LDLT) status. The group, headed by Dr. Tetsuro Sakai (SATA president), has investigated LDLT programs across the US. They have submitted their findings in an abstract to the 2022 IARS/AUA and ILTS meetings. They plan to prepare a manuscript of their findings. The committee has worked closely with the Korean Society of Anesthesiologists in an effort to write a collaborative review of LDLT practice, which they are planning to submit to Clinical Transplantation. 

The Q&S committee members have worked on several other research projects, including similar survey-based methods, investigating different organ transplantation services, and pursuing the development of SATA endorsed guidelines for our subspecialty.

News clips from the Executive Board of SATA

Lorenzo De Marchi, MD, Secretary, SATA

The SATA council wishes its members a happy holiday and new year.  We are always looking for ways to ensure SATA meets your needs.  Send us your suggestions.  We are listening.  Let us update you on the most recent and exciting projects in the works.  

Membership renewal:  We look forward to working with you in the upcoming year so don’t forget to renew for 2022.  There is easy access on the website. New members will receive six months free SATA membership.  Let your colleagues know. 

The SATA-Data Collection Project; a collaborative data collection project that extends the American College of Surgeons NSQIP to  anesthesia outcome measures of abdominal transplantation.  Headed by Dieter Adelman an anesthesiologist from UCSF and Stuart Greenstein, a surgeon from Montefiore.  If your center wants to participate, please reach out to Dr. Dieter Adelman (dieter.adelmann@ucsf.edu) and Dr. Sher-Lu Pai (pai.sherlu@mayo.edu) for information.

New Professional Associations: SATA and the Society for Cardiovascular Anesthesia have agreed to work together on shared interests in both heart and lung transplantation.  We thank SATA President Dr. Ted Sakai and SATA Treasurer Dr. Jiapeng Huang, in addition to  Dr. Archer Martin from SCA for their hard work on this project.

New Committee:  SATA approves new Critical Care Medicine Committee.  Please contact Dr. Ranjiit Deshpande through the SATA home link to apply and find out more.

Expanding SATA research:  Go to the web to apply for the Society’s endorsement for your research project. Submit your application to the SATA Secretary (demarchilorenzo@yahoo.com) for Council review and feedback.

Mark the calendar and pack your flipflop and sunscreen!!

The SATA annual meeting at the IARS is in Hawaii on Monday, March 21th, 2022 as an in-person meeting.  If you can’t be there don’t forget about upcoming SATA regional meetings with CME credits.  Check on the Society’s website for a complete list and dates.

Explore Educational Content

Webinars

August 2021: Rise of the Machines in Solid Organ Transplant

February 2021: Pro/Con Debate: Routine Anticoagulation in Liver Transplantation 

October 2020: Pro/Con Debate: ECMO vs Cardiopulmonary Bypass in Lung Transplantation 

June 2020: Transplant Anesthesiology during the COVID-19 Pandemic 

Vanguard Expert Lecture Series

June 2021: Evaluation for Lung Transplantation: Pulmonologist Perspective 

March 2021: Living Donor Liver Transplantation: Donor Management 

Fellowship Lecture Series

August 2021: Cardiovascular Assessment of Liver Transplantation Candidates 

June 2021: Multivisceral Transplantation 

May 2021: Acute Liver Failure 

Transplant Anesthesia Upcoming Meetings

SATA Meetings 

SATA West Coast Liver Transplant Anesthesia Meeting, December 11, 2021 9am – 12:30pm PST – Register for the Virtual Meeting

SATA Midwest Meeting, January 22nd, 2022; 8:55 am – 12:30 PM CST – Register for the Virtual Meeting

SATA National Meeting at IARS, March 21, 2022, Honolulu, HI

SATA Tristate Meeting, April 9th, 2022

Other Transplant Anesthesia Meetings

ILTS Virtual Consensus Conference January 28-29, 2022

IARS Annual Meeting March 18 – 21, 2022, Honolulu, HI

ILTS Annual Meeting May 4 – 7, 2022, Istanbul, Turkey
 
Are you enjoying the SATA Newsletter? Please fill out a quick survey!

 
BOARD OF DIRECTORS: TERM  2021 – 2022

President
Tetsuro Sakai, MD, PhD, MHA, FASA

Immediate Past President
M. Susan Mandell, MD, PhD

Founding President
Ernesto A. Pretto Jr., MD, MPH 

President-elect
Gebhard Wagener, MD

Secretary
Lorenzo De Marchi, MD

Treasurer
Jiapeng Huang, MD, PhD, FASA, FASE

Executive Council
Ranjit Deshpande MBBS
Adrian Hendrickse, BM, PgDipMEd, MAcadMEd, FRCA
Christine Nguyen-Buckley, MD
Ramona Nicolau-Raducu, MD, PhD

Newsletter Editor-in-Chief

Yong G Peng MD, PhD

Newsletter Editorial Board

Sennaraj Balasubramanian, MD
Amit Bardia, MD
Jiapeng Huang, MD, PhD, FASA, FASE
M. Susan Mandell, MD, PhD
Sergio Navarrete, DO
David Rosenfeld, MD
Flora Simmons, MD
Natalie Smith, MD
Michael Trostler MS, MD